EURETINA | articles

This year’s Barcelona meeting brought together award-winning research data and leaders in the retina field

Clare Bailey, MD, shared data from the multi-country study on faricimab for patients with DME and nAMD

Additional previous surgeries and the duration of the SO tamponade had little or no impact

How retinal imaging can provide clinicians a deeper understanding of myopia

The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission

Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk

Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies

Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.

A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies

The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients

Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences

Spotlight on the retina specialists who make up the Eye Care Network advisory boards

Businesses in the retina care space tease new technologies and cutting-edge therapeutics

As part of the Barcelona meeting, retina specialists can recognise the awareness day early

Focus on collaboration, career development and innovation

The Ramin Tadayoni Award supports the next generation of retina researchers while paying tribute to a leader in the field

At this year’s EURETINA meeting, retina specialists highlighted important developments in diabetic macular oedema and diabetic retinopathy research

The highlights from this year’s meeting, brought to you in conjunction with Modern Retina

Data indicated switching to SB15 from AFL maintained comparable clinical efficacy and safety, confirming biosimilarity between these agents

Case 1 highlights the potential for this treatment for patients with dry AMD with noted letter gains

The 23rd annual EURETINA Congress took place in Amsterdam, the Netherlands. We spoke with Arshad M. Khanani, MD, MA, FASRS, who provided an overview of his presentation, "Emerging therapies for exudative AMD"

Robyn Guymer, MBBS, PhD, Deputy Director, Centre for Eye Research Australia, and Professor of Surgery (Ophthalmology), University of Melbourne, Australia, discussed the study findings at the 23rd annual EURETINA Congress in Amsterdam, the Netherlands

We spoke with Michael Singer, MD who provided an overview of his presentation, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial"

The new range of pure and premixed gases are intended for medium-term use in retinal surgery

Attendees can take advantage of many satellite symposia, sponsored by industry and feauring experts from around the world

Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops

Companies are exploring light-sensitive proteins method in patients with advanced disease.

Data highlights need for educational materials and training resources in DMO and DR.

12-week interim results of BEHOLD, a proof-of-concept Phase 2a study investigating the candidate UBX1325, provides a positive outlook for a novel senolytic approach for previously-treated patients with diabetic macular oedema.

Eyecare specialists benefit from being able to monitor their patients long term for optimised and personalised treatment regimens, as well as having access to a more efficient workflow and one which enables them to see more patients.